Reference health
β-Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies
52/52 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 52 checked references that resolve
resolves10.1016/j.ejca.2014.08.006
Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer
resolves10.7314/APJCP.2013.14.10.6109
Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?
resolves10.1200/JCO.2010.33.5422
Beta Blockers and Breast Cancer Mortality: A Population- Based Study
resolves10.1007/s10549-013-2654-3
Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women
resolves10.1093/ije/dyt196
Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort
resolves10.1016/j.canep.2014.03.011
Beta-blocker usage and prostate cancer survival: A nested case–control study in the UK Clinical Practice Research Datalink cohort
resolves10.1016/j.jclinane.2013.10.004
Perioperative beta-blocker use and survival in lung cancer patients
resolves10.3109/10428194.2014.901513
The effect of calcium channel blockers on the outcome of acute myeloid leukemia
resolves10.1016/j.mayocp.2013.09.001
Effect of β-Blockers and Other Antihypertensive Drugs On the Risk of Melanoma Recurrence and Death
resolves10.1016/j.mayocp.2014.06.003
In reply—Effect of β-Adrenergic Blockers and Other Antihypertensive Drugs on the Risk of Melanoma Recurrence and Death
resolves10.1593/tlo.13346
Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer
resolves10.1007/s10549-011-1505-3
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
resolves10.1093/oxfordjournals.aje.a116237
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
resolves10.1158/1538-7445.PRCA2012-C61
Abstract C61: The use of beta blockers improve cancer-specific survival in prostate cancer patients receiving androgen deprivation therapy
resolves10.1002/pros.22564
Use of β‐blockers is associated with prostate cancer‐specific survival in prostate cancer patients on androgen deprivation therapy
resolves10.1016/j.eururo.2013.01.007
Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
resolves10.1093/annonc/mdt381
β-Blocker usage and colorectal cancer mortality: a nested case–control study in the UK Clinical Practice Research Datalink cohort
resolves10.1016/j.mayocp.2014.06.002
Effect of β-Adrenergic Blockers and Other Antihypertensive Drugs on the Risk of Melanoma Recurrence and Death—II
resolves10.1007/s10549-013-2553-7
Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use
resolves10.1016/j.canep.2013.09.001
Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study
resolves10.1002/cncr.28546
Stage‐specific associations between beta blocker use and prognosis after colorectal cancer
resolves10.1186/1471-2407-13-85
Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study
resolves10.1016/j.ejca.2007.12.015
Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
resolves10.1158/1055-9965.EPI-11-0249
β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
resolves10.1136/bmj.b5087
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
resolves10.1016/j.ejca.2013.07.141
β-Blocker use and all-cause mortality of melanoma patients: Results from a population-based Dutch cohort study
resolves10.1111/bjd.12894
Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study
resolves10.1200/JCO.2010.33.4441
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
resolves10.7326/0003-4819-151-4-200908180-00135
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
resolves10.1016/j.mayocp.2014.06.001
Effect of β-Adrenergic Blockers and Other Antihypertensive Drugs on the Risk of Melanoma Recurrence and Death—I
resolves10.18632/oncotarget.197
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
resolves10.1111/j.1365-2125.2011.03980.x
Does β‐adrenoceptor blocker therapy improve cancer survival? Findings from a population‐based retrospective cohort study
resolves10.1136/bmjopen-2014-007299
Can analyses of electronic patient records be independently and externally validated? Study 2—the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study
resolves10.3102/10769986030003261
Bias and Efficiency of Meta-Analytic Variance Estimators in the Random-Effects Model
resolves10.1093/annonc/mds616
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
resolves10.1016/j.cllc.2014.09.006
Incidental Receipt of Cardiac Medications and Survival Outcomes Among Patients With Stage III Non–Small-Cell Lung Cancer After Definitive Radiotherapy
resolves10.1007/s00432-009-0587-3
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
resolves10.1016/j.ijcard.2014.10.028
The incidence of cancer deaths among hypertensive patients in a large Chinese population: A cohort study
resolves10.1007/s10654-014-9916-1
Association between physical activity and mortality in breast cancer: a meta-analysis of cohort studies
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1097/cej.0000000000000192"><img src="https://citestamp.com/citestamped/10.1097/cej.0000000000000192/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1097/cej.0000000000000192)